We have located links that may give you full text access.
Impact of left bundle branch block on heart failure with preserved ejection fraction.
Pacing and Clinical Electrophysiology : PACE 2023 March 19
BACKGROUND: The implications of LBBB in heart failure with preserved ejection fraction (HFpEF) is unclear. Our study assesses clinical outcomes among patients with LBBB and HFpEF who were admitted with acute decompensated heart failure.
METHODS: This is a cross-sectional study was conducted using the National Inpatient Sample (NIS) database from 2016-2019.
RESULTS: We found 74,365 hospitalizations with HFpEF and LBBB and 3,892,354 hospitalizations with HFpEF without LBBB. Patients with LBBB were older (78.9 vs 74.2 years) and had higher rates of coronary artery disease (53.05% vs 40.8%), hypertension (74.7% vs 70.8%), atrial fibrillation (32.8% vs 29.4%), sick sinus rhythm (3.4% vs 2.02%), complete heart block (1.8% vs 0.66%), ventricular tachycardia (3.5% vs 1.7%), and ventricular fibrillation (0.24% vs 0.11%). Patients with LBBB were found to have decreased in-hospital mortality (OR: 0.85; 0.76-0.96; p-0.009) but higher rates of cardiac arrest (OR: 1.39; 1.06-1.83; p-0.02) and need for mechanical circulatory support (OR: 1.7; 1.28-2.36; p-0.001). Patients with LBBB underwent a higher rate of pacemaker (OR: 2.98; 2.75-3.23; p < 0.001) and ICD (implantable cardioverter-defibrillator) placement (OR: 3.98; 2.81-5.62; p < 0.001). Patients with LBBB were also found to have a higher mean cost of hospitalization ($81,402 vs $60,358; p < 0.001) but lower length of stay (4.8 vs 5.4 days; p < 0.001).
CONCLUSION: In patients admitted with decompensated heart failure with preserved ejection fraction, left bundle branch block is associated with increased odds of cardiac arrest, mechanical circulatory support requirement, device implantation and mean cost of hospitalization but decreased odds of in-hospital mortality.
METHODS: This is a cross-sectional study was conducted using the National Inpatient Sample (NIS) database from 2016-2019.
RESULTS: We found 74,365 hospitalizations with HFpEF and LBBB and 3,892,354 hospitalizations with HFpEF without LBBB. Patients with LBBB were older (78.9 vs 74.2 years) and had higher rates of coronary artery disease (53.05% vs 40.8%), hypertension (74.7% vs 70.8%), atrial fibrillation (32.8% vs 29.4%), sick sinus rhythm (3.4% vs 2.02%), complete heart block (1.8% vs 0.66%), ventricular tachycardia (3.5% vs 1.7%), and ventricular fibrillation (0.24% vs 0.11%). Patients with LBBB were found to have decreased in-hospital mortality (OR: 0.85; 0.76-0.96; p-0.009) but higher rates of cardiac arrest (OR: 1.39; 1.06-1.83; p-0.02) and need for mechanical circulatory support (OR: 1.7; 1.28-2.36; p-0.001). Patients with LBBB underwent a higher rate of pacemaker (OR: 2.98; 2.75-3.23; p < 0.001) and ICD (implantable cardioverter-defibrillator) placement (OR: 3.98; 2.81-5.62; p < 0.001). Patients with LBBB were also found to have a higher mean cost of hospitalization ($81,402 vs $60,358; p < 0.001) but lower length of stay (4.8 vs 5.4 days; p < 0.001).
CONCLUSION: In patients admitted with decompensated heart failure with preserved ejection fraction, left bundle branch block is associated with increased odds of cardiac arrest, mechanical circulatory support requirement, device implantation and mean cost of hospitalization but decreased odds of in-hospital mortality.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app